Mount Miriam Cancer Hospital
Tanjung Bungah, Malaysia
Cancer treatment center in Tanjung Bungah
23, Jalan Bulan Tanjung Bungah, 11200 George Town, Pulau Pinang
About Mount Miriam Cancer Hospital
"Mount Miriam is the home to the best and biggest clinical oncology and cancer care team in the region with cutting-edge robotic radiosurgery – Cyberknife. Mount Miriam, a place where the excellence in cancer care and affordable treatment meets."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mount Miriam Cancer Hospital
During the past decade, Mount Miriam Cancer Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mount Miriam Cancer Hospital" #1 sponsor was "Arcus Biosciences, Inc." with 1 trials, followed by "Eli Lilly and Company" with 1 trials
sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Miriam Cancer Hospital"
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Mount Miriam Cancer Hospital
According to Clinical.Site data, the most researched conditions in "Mount Miriam Cancer Hospital" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Lung Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Mount Miriam Cancer Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Mount Miriam Cancer Hospital
Most popular intervention types in "Mount Miriam Cancer Hospital" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (2 trials), "Pemetrexed" (2 trials), "Abemaciclib" (1 trials) and "Amivantamab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mount Miriam Cancer Hospital
The vast majority of trials in "Mount Miriam Cancer Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Mount Miriam Cancer Hospital
Currently, there are NaN active trials in "Mount Miriam Cancer Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Mount Miriam Cancer Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mount Miriam Cancer Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".